Chronic hyperprolactinemia and changes in dopamine neurons

被引:23
|
作者
Mohankumar, PS
Mohankumar, SMJ
Kaleem, S
Quadri, SK
Voogt, JL
机构
[1] UNIV KANSAS,MED CTR,DEPT PHYSIOL,KANSAS CITY,KS 66160
[2] KANSAS STATE UNIV,DEPT ANAT & PHYSIOL,MANHATTAN,KS 66506
关键词
prolactin; catecholamines; aging; microdissection; HPLC-EC;
D O I
10.1016/S0361-9230(96)00369-3
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
The tuberoinfundibular dopaminergic (TIDA) system is known to inhibit prolactin (PRL) secretion. In young animals this system responds to acute elevations in serum PRL by increasing its activity. However, this responsiveness is lost in aging rats with chronically high serum PRL levels. The purpose of this study was to induce hyperprolactinemia in rats for extended periods of time and examine its effects on dopaminergic systems in the brain. Hyperprolactinemia was induced by treatment with haloperidol, a dopamine receptor antagonist, and Palkovits' microdissection technique in combination with high-performance liquid chromatography was used to measure neurotransmitter concentrations in several areas of the brain. After 6 months of hyperprolactinemia, dopamine (DA) concentrations in the median eminence (ME) increased by 84% over the control group. Nine months of hyperprolactinemia produced a 50% increase in DA concentrations in the ME over the control group. However, DA response was lost if a 9-month long haloperidol-induced hyperprolactinemia was followed by a 1 1/2, month-long extremely high increase in serum PRL levels produced by implantation of MMQ cells under the kidney capsule. There was no change in the levels of DA, norepinephrine (NE), serotonin (5-HT), or their metabolites in the arcuate nucleus (AN), medial preoptic area (MPA), caudate putamen (CP), substantia nigra (SN), and zona incerta (ZI), except for a decrease in 5-hydroxyindoleacetic acid (5-HIAA) in the AN after B-months of hyperprolactinemia and an increase in DA concentrations in the AN after g-months of hyperprolactinemia. These results demonstrate that hyperprolactinemia specifically affects TIDA neurons and these effects vary, depending on the duration and intensity of hyperprolactinemia. The age-related decrease in hypothalamic dopamine function may be associated with increases in PRL secretion. (C) 1997 Elsevier Science Inc.
引用
收藏
页码:435 / 441
页数:7
相关论文
共 50 条
  • [1] CHRONIC HYPERPROLACTINEMIA DISRUPTS FUNCTION IN HYPOTHALAMIC DOPAMINE NEURONS
    SIMPKINS, JW
    GABRIEL, SM
    [J]. FEDERATION PROCEEDINGS, 1983, 42 (03) : 728 - 728
  • [2] CHRONIC HYPERPROLACTINEMIA CAUSES PROGRESSIVE CHANGES IN HYPOTHALAMIC DOPAMINERGIC AND NORADRENERGIC NEURONS
    SIMPKINS, JW
    GABRIEL, SM
    [J]. BRAIN RESEARCH, 1984, 309 (02) : 277 - 282
  • [3] Effects of chronic hyperprolactinemia on tuberoinfundibular dopaminergic neurons
    MohanKumar, PS
    MohanKumar, SMJ
    Arbogast, L
    Quadri, SK
    Voogt, JL
    [J]. PROCEEDINGS OF THE SOCIETY FOR EXPERIMENTAL BIOLOGY AND MEDICINE, 1998, 217 (04): : 461 - 465
  • [4] Chronic morphine induces visible changes in the morphology of mesolimbic dopamine neurons
    SklairTavron, L
    Shi, WX
    Lane, SB
    Harris, HW
    Bunney, BS
    Nestler, EJ
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (20) : 11202 - 11207
  • [5] DOPAMINE AGONISTS IN HYPERPROLACTINEMIA
    MATTOX, JH
    [J]. FERTILITY AND STERILITY, 1985, 44 (04) : 555 - 556
  • [6] GABAERGIC BIOCHEMICAL PARAMETERS OF THE TUBEROINFUNDIBULAR NEURONS FOLLOWING CHRONIC HYPERPROLACTINEMIA
    FELMAN, K
    TAPPAZ, M
    [J]. NEUROENDOCRINOLOGY, 1989, 49 (06) : 580 - 585
  • [7] CHRONIC HYPERPROLACTINEMIA DEPLETES HYPOTHALAMIC DOPAMINE CONCENTRATIONS IN MALE-RATS
    SIMPKINS, JW
    HODSON, CA
    KALRA, PS
    KALRA, SP
    [J]. LIFE SCIENCES, 1982, 30 (16) : 1349 - 1353
  • [8] Dopamine agonist therapy or hyperprolactinemia
    Bankowski, BJ
    Zacur, HA
    [J]. CLINICAL OBSTETRICS AND GYNECOLOGY, 2003, 46 (02): : 349 - 362
  • [9] Dopamine agonist therapy in hyperprolactinemia
    Webster, J
    [J]. JOURNAL OF REPRODUCTIVE MEDICINE, 1999, 44 (12) : 1105 - 1110
  • [10] DOPAMINE AGONISTS IN HYPERPROLACTINEMIA - REPLY
    BLACKWELL, RE
    RODGERSNEAME, NT
    [J]. FERTILITY AND STERILITY, 1985, 44 (04) : 556 - 557